These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 19106512)

  • 21. [Clinical effect of transcatheter arterial chemoembolization combined with high intensity focused ultrasound ablation in treatment of large hepatocellular carcinoma].
    Li CX; Wu PH; Fan WJ; Huang JH; Zhang FJ; Zhang L; Gu YK; Zhao M; Gao F; Jiao DC
    Zhonghua Yi Xue Za Zhi; 2009 Mar; 89(11):754-7. PubMed ID: 19595104
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
    Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The effect of partial splenic embolization (PSE) on liver function test in patients with liver cirrhosis].
    Nomiyama K; Akagi K; Watanabe H; Kajiwara E; Sakino I
    Fukuoka Igaku Zasshi; 1991 Mar; 82(3):105-9. PubMed ID: 2066049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Influence of preoperative transcatheter arterial chemoembolization on liver resection in patients with resectable hepatocellular carcinoma.
    Luo YQ; Wang Y; Chen H; Wu MC
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):523-6. PubMed ID: 14607679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Simultaneous CSM-TACE with CalliSpheres
    Zhou J; Feng Z; Liu S; Li X; Liu Y; Gao F; Shen J; Zhang YW; Zhao GS; Zhang M
    Front Oncol; 2022; 12():998500. PubMed ID: 36530976
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of preoperative partial splenic embolization in hepatocellular carcinoma and hypersplenic thrombocytopenia.
    Yoshidome H; Kimura F; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takeuchi D; Takayashiki T; Suda K; Takano S; Miyazaki M
    Hepatogastroenterology; 2011; 58(112):2062-6. PubMed ID: 22234078
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant transcatheter arterial chemoembolization improves efficacy of hepatectomy for patients with hepatocellular carcinoma and portal vein tumor thrombus.
    Peng BG; He Q; Li JP; Zhou F
    Am J Surg; 2009 Sep; 198(3):313-8. PubMed ID: 19285298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination therapy with transarterial chemoembolization and interferon-alpha compared with transarterial chemoembolization alone for hepatitis B virus related unresectable hepatocellular carcinoma.
    Li M; Lu C; Cheng J; Zhang J; Cao C; Xu J; Xu J; Pan H; Zhong B; Tucker S; Wang D
    J Gastroenterol Hepatol; 2009 Aug; 24(8):1437-44. PubMed ID: 19486255
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and Safety of Transarterial Chemoembolization and Repeated Partial Splenic Embolization for Hepatocellular Carcinoma with Hypersplenism and Thrombocytopenia.
    Hong W; Wang Z; Yao W; Zhang X; Zhang L; Liang B
    J Hepatocell Carcinoma; 2024; 11():1065-1078. PubMed ID: 38882439
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
    Fan WJ; Zhang L; Ouyang YS
    Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reappraisal of repeated transarterial chemoembolization in the treatment of hepatocellular carcinoma with portal vein invasion.
    Kim KM; Kim JH; Park IS; Ko GY; Yoon HK; Sung KB; Lim YS; Lee HC; Chung YH; Lee YS; Suh DJ
    J Gastroenterol Hepatol; 2009 May; 24(5):806-14. PubMed ID: 19207681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pilot study of transarterial chemoembolization with pirarubicin and amiodarone for unresectable hepatocellular carcinoma.
    Guiu B; Colin C; Cercueil JP; Loffroy R; Guiu S; Ferrant E; Jouve JL; Bonnetain F; Boulin M; Ghiringhelli F; Minello A; Hillon P; Bedenne L; Krause D; Chauffert B
    Am J Clin Oncol; 2009 Jun; 32(3):238-44. PubMed ID: 19349854
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoembolization combined with pravastatin improves survival in patients with hepatocellular carcinoma.
    Graf H; Jüngst C; Straub G; Dogan S; Hoffmann RT; Jakobs T; Reiser M; Waggershauser T; Helmberger T; Walter A; Walli A; Seidel D; Goke B; Jüngst D
    Digestion; 2008; 78(1):34-8. PubMed ID: 18797167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent partial splenic embolization with transcatheter arterial chemoembolization for hepatocellular carcinoma can maintain hepatic functional reserve.
    Ishikawa T; Kubota T; Horigome R; Kimura N; Honda H; Iwanaga A; Seki K; Honma T; Yoshida T
    Hepatol Res; 2014 Oct; 44(11):1056-61. PubMed ID: 23941627
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of preoperative transarterial chemoembolization of resectable hepatocellular carcinoma on clinical and economic outcomes.
    Lee KT; Lu YW; Wang SN; Chen HY; Chuang SC; Chang WT; Shi HY; Ker CG; Chiu HC
    J Surg Oncol; 2009 May; 99(6):343-50. PubMed ID: 19226530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
    Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
    Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Partial splenic embolization using polyvinyl alcohol particles for hypersplenism in cirrhosis: a prospective randomized study.
    Zhu K; Meng X; Li Z; Huang M; Guan S; Jiang Z; Shan H
    Eur J Radiol; 2008 Apr; 66(1):100-6. PubMed ID: 17532166
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial splenic embolization for the treatment of hypersplenism in cirrhosis.
    Sangro B; Bilbao I; Herrero I; Corella C; Longo J; Beloqui O; Ruiz J; Zozaya JM; Quiroga J; Prieto J
    Hepatology; 1993 Aug; 18(2):309-14. PubMed ID: 8340060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinico-roentogenologic findings in hepatocellular carcinoma fed by the right inferior phrenic artery at the initial chemoembolization.
    Kimura S; Okazaki M; Higashihara H; Haruno M; Nozaki Y; Urakawa H; Kora S; Shinagawa Y; Nonokuma M
    Hepatogastroenterology; 2009; 56(89):191-8. PubMed ID: 19453056
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple hepatic arterial injections of recombinant adenovirus p53 and 5-fluorouracil after transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a pilot phase II trial.
    Tian G; Liu J; Zhou JS; Chen W
    Anticancer Drugs; 2009 Jun; 20(5):389-95. PubMed ID: 19287305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.